Paper660450
Bioavailability of erythromycin stearate: influence of food and fluid volume.
Welling PG and 3 others. J Pharm Sci, 1978. Cited by 55 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Bioavailability of erythromycin stearate: influence of food and fluid volume. Papers, record 660450. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/660450
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drinking | Major topic |
| Erythromycin | Major topic |
| Food | Major topic |
| Adult | |
| Biological Availability | |
| Female | |
| Humans | |
| Intestinal Absorption | |
| Male |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,225,260 | Long-Chained Fatty Acid-Based Solid Dispersions of Voriconazole as an Effective Strategy For Achieving Sustained Release. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/41225260 | PubMed |
| 29,076,109 | A Review of Food-Drug Interactions on Oral Drug Absorption. | Drugs | 2017 | https://conductscience.org/library/papers/29076109 | PubMed |
| 27,106,837 | Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine. | AAPS J | 2016 | https://conductscience.org/library/papers/27106837 | PubMed |
| 12,093,316 | Food-drug interactions. | Drugs | 2002 | https://conductscience.org/library/papers/12093316 | PubMed |
| 7,727,050 | Drug interactions with antacids. Mechanisms and clinical significance. | Drug Saf | 1994 | https://conductscience.org/library/papers/7727050 | PubMed |
| 7,306,427 | Absorption and bioavailability of oral erythromycin. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7306427 | PubMed |
| 7,283,417 | Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7283417 | PubMed |
| 7,082,537 | Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082537 | PubMed |
| 6,969,579 | Influence of food on absorption of erythromycin ethyl succinate. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6969579 | PubMed |
| 6,511,088 | Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast. | Infection | 1984 | https://conductscience.org/library/papers/6511088 | PubMed |
| 2,367,321 | Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data. | Pharm Res | 1990 | https://conductscience.org/library/papers/2367321 | PubMed |
| 512,842 | Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/512842 | PubMed |
| 508,509 | The influence of food on the bioavailability of new formulations of erythromycin stearate and base. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/508509 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/660450
GET https://conductscience.org/api/papers/v1/660450/authors